The Institute for Research in Biomedicine was founded in 2000 with the goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.
The IRB benefits from a wide international network of collaborations.
In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.
New paper from the Guarda Lab
The phosphatase Shp-2 has been suggested to regulate signaling downstream of NK cell inhibitory receptors, which are essential to calibrate NK cell responsiveness;... Read more
Designed Protein-Nanoparticle Vaccine against Respiratory Syncytial Virus, a study from the Perez’s lab published in Cell
A collaborative project between the Institute for Research in Biomedicine (IRB) affiliated to the Università della Svizzera italiana (USI), the Institute for Protein... Read more
New paper from the González Lab
The role of natural killer (NK) cells in the immune response against vaccines is not fully understood. This study, published in Cell Reports, determined the function of... Read more
Two publications from Cejka’s laboratory describe how cells repair broken DNA
DNA bears all genetic information required for proper development and function of all living organisms. DNA molecule is however prone to breakage, threatening cell... Read more
New study by the Monticelli’s lab on epigenetic modifications in human T cells
This study, performed primarily by Lucia Vincenzetti, was recently published in the European Journal of Immunology. Epigenetic modifications such as DNA methylation are... Read more
9° giornata della Ricerca della Svizzera italiana – Best original publication 2018 over 35 and best talk awarded to Samuele Notarbartolo and Alessandro Marazza, respectively